Inflammatory cytokines have been suggested to activate specific signaling pathways that reduce the levels of growth hormones (GH and IGF-1), resulting in reduced protein anabolism, increased skeletal muscle atrophy, and, finally, sarcopenia [19,20]. The gene discussed is GH1; the disease is sarcopenia.